When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Celgene files European application for luspatercept
Acceleron Pharma Inc.
Celgene (NASDAQ:CELG) has submitted a marketing application Europe seeking approval for luspatercept for the treatment of adult patients with very low to intermediate-risk myelodysplastic syndromes-associated anemia who have ring sideroblasts, require red blood cell (RBC) transfusions and have received or are not eligible for erythropoiesis-stimulating agents, and for the treatment of adult patients with beta-thalassemia-associated anemia who require RBC transfusions.
More news on: Celgene Corporation, Acceleron Pharma Inc., Healthcare stocks news,